Résumé
Methods and software tools for optimal design in nonlinear mixed effect models, based on the Fisher information matrix, have been developed for a decade.1,2 Academic groups regularly proposed new versions.3-5 Present tools do not incorporate adaptive designs for these models although prior information is needed and adaptive designs are increasingly used in drug development.6 We conducted a study among drug companies of the Drug and Disease Model Resources consortium7 to identify current practices and expectations.
| langue originale | Anglais |
|---|---|
| Numéro d'article | e46 |
| journal | CPT: Pharmacometrics and Systems Pharmacology |
| Volume | 2 |
| Numéro de publication | 6 |
| Les DOIs | |
| état | Publié - 1 juin 2013 |
| Modification externe | Oui |
Empreinte digitale
Examiner les sujets de recherche de « Current use and developments needed for optimal design in pharmacometrics: A study performed among ddmore's european federation of pharmaceutical industries and associations members ». Ensemble, ils forment une empreinte digitale unique.Contient cette citation
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver